Brooks O'Neil
Stock Analyst at Lake Street
(0.67)
# 4,038
Out of 5,182 analysts
34
Total ratings
29.41%
Success rate
-19.76%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $3.61 | +177.01% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $5.09 | +57.17% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $19.87 | -39.61% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.28 | +86.92% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $2.85 | +601.75% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $111.53 | -1.37% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $10.22 | +193.54% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $5.14 | +406.33% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $40.20 | +36.82% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $10.33 | +74.25% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.81 | +127.01% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.56 | +95.31% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $25.56 | +1.72% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $330 | $4.07 | +8,008.11% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $15.64 | +715.22% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $3.61
Upside: +177.01%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $5.09
Upside: +57.17%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $19.87
Upside: -39.61%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.28
Upside: +86.92%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $2.85
Upside: +601.75%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $111.53
Upside: -1.37%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $10.22
Upside: +193.54%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $5.14
Upside: +406.33%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $40.20
Upside: +36.82%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $10.33
Upside: +74.25%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.81
Upside: +127.01%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.56
Upside: +95.31%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $25.56
Upside: +1.72%
Apr 8, 2022
Initiates: Buy
Price Target: $330
Current: $4.07
Upside: +8,008.11%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $15.64
Upside: +715.22%